The plasma retinol levels as pro-oxidantoxidant agents in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 24, Issue 7, 2009, Pages 2212-2218

  Roehrs, Miguel ^a,b   Valentini, Juliana ^b   Bulcão, Rachel ^b   Moreira, José Cláudio ^b   Biesalski, Hanz ^c   Limberger, Renata P ^b   Grune, Tilman ^c   Garcia, Solange Cristina ^b  

^a Post graduate Program of Pharmacology   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

ALA D activity; Haemodialysis patients; MDA; Oxidative stress; Plasma retinol levels

Indexed keywords

BIOLOGICAL MARKER; CATALASE; MALONALDEHYDE; OXIDIZING AGENT; PORPHOBILINOGEN SYNTHASE; RETINOL; SUPEROXIDE DISMUTASE;

ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HEMODIALYSIS PATIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; MALE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETRY; TISSUE INJURY; ULTRAVIOLET SPECTROSCOPY;

ADULT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; VITAMIN A;

EID: 67651087413     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp001     Document Type: Article

References (55)

1. Dakshinamurty KV, Srinivasa Rao PVLN, Saibaba KSS et al. Antioxidant status in patients on maintenance haemodialysis. Indian J Nephrol 2002; 12: 77-80
2. Bloembergen WE, Port FK, Mauger EA et al. Causes of death in dialysis patients: racial and gender differences. Am J Kidney Dis 1994; 5: 1231-1242
3. Yeun JY, Levine RA, Mantadiok V et al. C-reactive protein predicts all-cause and cardiovascular mortality in haemodialysis patients. Am J Kidney 2000; 35: 469-476
4. Lowrie EG, Lew NL. Death risk in hemodialys patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482
5. Abd El Maksoud AM, Abd Allah AM, Massoud W et al. Retinol and alpha-tocopherol levels among haemodialysis patients. EgyptJHosp Med 2000; 15: 65-71
6. Murata M, Kawanishi S. Oxidative DNA damage by vitamin A and its derivates via superoxide generation. JBiolChem 2000; 275: 2003-2008
7. Goodman DS. Vitamin A and retinoids in health and disease. N Engl JMed 1984; 16: 1023-1031
8. Napoli JL. Biochemical pathways of retinoid transport, metabolism and signal transduction. Clin Immunol Immunopathol 1996; 80: S52-S62
9. Blaner WS, Olson JA. Retinol and acid retinoic metabolism. In: Sporn MB, Roberts AB, Goodman DS (eds). The Retinoids, Biology, Chemistry and Medicine. New York: Raven Press, 1994, 229-256
10. Kanai MA, Raz, Goodman De WS. Retinol binding protein: the transport binding protein: the transport protein for vitamin A in human plasma. J Clin Invest 1968; 47: 2025-2044
11. Muto Y, Goodman DWS. Vitamin A transport in rat plasma. Isolation and characterization of retinol-binding protein. JBiolChem 1972; 247: 2533-2541
12. Vogel S, Gamble MV, Blaner WS. Biosynthesis, absorption, metabolism and transport of retinoids. In: Nau H, Blaner WS (eds). Handbook of Experimental Pharmacology. Heidelberg: Springer, 1999; 31-95
13. Ceballos IP, Nicole A, Clement M, Bourre JM. Age-related changes in antioxidant enzymes and lipid peroxidation in brains of control and transgenic mice overexpressing copper-zinc superoxide dismutase. Mutat Res 1992; 275: 281-293
14. 2+ ions. Comp Biochem Physiol 1988; 91B: 285-291
15. Rocha JBT, Pereira ME, Emanuelli T et al. Effects of mercury chloride and lead acetate treatment during the second stage of rapid postnatal brain growth on ALA-D activity brain, liver, kidney and blood of suckling rats. Toxicology 1995; 100: 27-37
16. Rocha JBT, Tuerlinckx SM, Schetinger MRC et al. Effects of group 13 metals on porphobilinogen synthase in vitro. Toxicol Appl Pharmacol 2004; 200: 169-176
17. Bechara EJH, Medeiros MHG, Monteiro HP. A free radical hypothesis of lead poisoning and inborn porphyries associated with 5-aminolevulinic acid overload. Quim Nova 1993; 16: 385-392
18. Pereira B, Curi R, Kokubun E et al. 5-Aminolevulinic acid-induced alterations of oxidative metabolism in sedentary and exercise-trained rats. J Appl Physiol 1992; 72: 226-230
19. Buchet JP, Lauwerys R, Hassoun A et al. Effect of aluminum on porphyrin metabolism in hemodialyzed patients. Nephron 1987; 46: 360-363
20. Djordjevic VB, Strahinjic S, Karacevic D et al. Erythrocyte delta-aminolevulinate dehydratase measurements in Balkan endemic nephropathy. Kidney Int Suppl 1991; 34: S96-S96
21. Fontanellas A, Herrero JA, Coronel F et al. Effects of recombinant human erythropoietin on porphyrin metabolism in uremic patients on haemodialysis. J Am Soc Nephrol 1996; 7: 774-779
22. Voss P, Siems W. Clinical oxidation parameters of aging. Free Radic Res 2006; 40: 1339-1349
23. Valentini J, Grotto D, Paniz C et al. The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients. Biomed Pharmacother 2008; 62: 378-382
24. Ono K, Waki Y, Takeda K. Hypervitaminosis A: a contributing factor to anemia in regular dialysis patients. Nephron 1984; 38: 44-47
25. Fishbane S, Frei GL, Finger M et al. Hypervitaminosis A in two haemodialysis patients. Am J Kidney Dis 1995; 25: 346-349
26. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). JBiolChem 1969; 244: 6049-6055
27. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126
28. Rock CL, Jahnke MG, Gorenflo DW et al. Antioxidant vitamins in hemodialysis. Am J Clin Nutr 1997; 65: 844-850
29. Zima T, Janebová M, Nemecek K et al. Retinol and alpha-tocopherol in haemodialysis patients. Ren Fail 1998; 20: 505-512
30. El Maksoud A, Awatif M, Allah A et al. Retinol and alpha-tocopherol levels among haemodialysis patients. Egypt J Hosp Med 2004; 15: 65-71
31. Frey SK, Nagl B, Henze A et al. Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver. Lipid Healthy Dis 2008; 7: 29
32. Thomas H Gerlach, Maija H Zile. Metabolism and secretion of retinol transport complex in acute renal failure. J Lipid Res 1991; 32: 515-520
33. Muth I. Implications of hypervitaminosis A in chronic renal failure. J Renal Nutr 1991; 1: 2-8
34. 3H] thymidine incorporation induced by retinol treatment in Sertoli cells. Med Sci Res 1996; 24: 383-384
35. Moreira JCF, Dal-Pizol F, Rocha AB et al. Retinol-induced changes in the phosphorylation of histones and high mobility group proteins from Sertoli cells. Braz J Med Biol Res 2000; 33: 287-293
36. Dal-Pizol F, Klmat F, Frota MLC et al. Retinol supplementation induces DNA damage and modulates iron turnover in rat Sertoli cells. Free Radic Res 2000; 32: 677-687
37. Oliveira MR, Pasquali MAB, Silvestrin RB et al. Vitamin A supplementation induces a pro oxidative state in the striatum and impairs locomotory and exploratory activity of adult rats. Brain Res 2007; 1169: 112-119
38. Evelyne P, Carbonneau MA, Doubourg L. Lipid peroxidation in plasma and red blood cels of patients undergoing haemodialysis. Vitamins A, E and iron status. Free Radic Biol Med 1994; 16: 339-349
39. Valentini J, Schmitt GC, Grotto D et al. Human erythrocyte δ-aminolevulinate dehydratase activity and oxidative stress in haemodialysis patients. Clin Biochem 2007; 40: 591-594
40. Hernández AF, López O, Rodrigo L et al. Changes in erythrocyte enzymes in humans long-term exposed to pesticides. Influence of several markers of individual susceptibility. Toxicol Lett 2005; 159: 13-21
41. Gabriel D, Pivetta L, Folmer V et al. Human erythrocyte δ-aminolevulinate dehydratase inhibition by monosaccharides is not mediated by oxidation of enzyme sulfhydryl groups. Cell Biol Inter 2005; 29: 669-674
42. Schmidtmann S, Von Baehr R, Precht K. Free radicals induce increased lysis of red blood cells after haemodialysis. Nephrol Dial Transplant 1990; 5: 600-603
43. Mimic-Oka J, Simic T, Djukanovic L et al. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin Nephrol 1999; 51: 233-241
44. Laporte F, Foret M, Favier A et al. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991; 57: 10-15
45. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 1996; 21: 845-853
46. Mimic-Oka J, Simic T, Ekmescic V et al. Erythrocyte glutathione peroxidase and superoxide dismutase activities in different stages of chronic renal failure. Clin Nephrol 1995; 44: 44-48
47. Dasgupta A, Hussain S, Ahmad S. Increased lipid peroxidation in patients on maintenance haemodialysis. Nephron 1992; 60: 56-59
48. Lucchi L, Banni S, Capelli B et al. Conjugated diene fatty acids in patients with chronic renal failure: evidence of increased lipid peroxidation? Nephron 1993; 65: 401-409
49. Dursun E, Ozben T, Suleymanlar G et al. Effect of haemodialysis on the oxidative stress and antioxidants. Clin Chem Lab Med 2002; 40: 1009-1013
50. Konukoglu D, Ercan M, Ayaz M et al. Plasma and erythrocytes antioxidant status and trace element levels in proteinuric patients with moderate glomerular function. J Trace Elem Med Biol 2001; 15: 119-122
51. Kamezaki TC, Nagai Y, Kikuchi H et al. Favorable effect of haemodialysis on decreased serum antioxidant activity in haemodialysis patients demonstrated by electron spin resonance. J Am Soc Nephrol 1997; 8: 1157-1163
52. Ozden M, Maral H, Akaydin D et al. Erythrocyte glutathione peroxidase activity, plasma malonyldialdehyde and erythrocyte glutathione levels in haemodialysis and CAPD patients. Clin Biochem 2002; 35: 269-273
53. Paul JL, Sall ND, Soni T et al. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 1993; 64: 106-109
54. Vanella A, Geremia E, Pinturo R et al. Superoxide dismutase activity and reduced glutathione content in erythrocytes of uremic patients on chronic dialysis. Acta Haematol 1983; 70: 312-315
55. Zachara BA, Adamowicz A, Trafikowska U et al. Selenium and glutathione levels and glutathione peroxidase activities in blood component of uremic patients on haemodialysis supplemented with selenium and treated with erythropoietin. J Trace Elem Med Biol 2001; 15: 201-208